254 related articles for article (PubMed ID: 29959116)
21. SOX6 Downregulation Induces
Li J; Lai Y; Luo J; Luo L; Liu R; Liu Z; Zhao W
Biomed Res Int; 2017; 2017():9496058. PubMed ID: 29333458
[TBL] [Abstract][Full Text] [Related]
22. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.
Paschoudi K; Yannaki E; Psatha N
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298481
[TBL] [Abstract][Full Text] [Related]
23. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
24. Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
Weber L; Frati G; Felix T; Hardouin G; Casini A; Wollenschlaeger C; Meneghini V; Masson C; De Cian A; Chalumeau A; Mavilio F; Amendola M; Andre-Schmutz I; Cereseto A; El Nemer W; Concordet JP; Giovannangeli C; Cavazzana M; Miccio A
Sci Adv; 2020 Feb; 6(7):. PubMed ID: 32917636
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
[TBL] [Abstract][Full Text] [Related]
26. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.
Hanawa H; Hargrove PW; Kepes S; Srivastava DK; Nienhuis AW; Persons DA
Blood; 2004 Oct; 104(8):2281-90. PubMed ID: 15198957
[TBL] [Abstract][Full Text] [Related]
27. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
Qian X; Chen J; Zhao D; Guo L; Qian X
Int J Mol Med; 2013 Jun; 31(6):1418-28. PubMed ID: 23588991
[TBL] [Abstract][Full Text] [Related]
28. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.
Li C; Georgakopoulou A; Newby GA; Everette KA; Nizamis E; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36006707
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1.
Ma SP; Xi HR; Gao XX; Yang JM; Kurita R; Nakamura Y; Song XM; Chen HY; Lu DR
Biochem Biophys Res Commun; 2021 May; 552():157-163. PubMed ID: 33744764
[TBL] [Abstract][Full Text] [Related]
30. Recent trends for novel options in experimental biological therapy of β-thalassemia.
Finotti A; Gambari R
Expert Opin Biol Ther; 2014 Oct; 14(10):1443-54. PubMed ID: 24934764
[TBL] [Abstract][Full Text] [Related]
31. Inducing indel mutation in the SOX6 gene by zinc finger nuclease for gamma reactivation: An approach towards gene therapy of beta thalassemia.
Modares Sadeghi M; Shariati L; Hejazi Z; Shahbazi M; Tabatabaiefar MA; Khanahmad H
J Cell Biochem; 2018 Mar; 119(3):2512-2519. PubMed ID: 28941328
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters.
Breveglieri G; Salvatori F; Finotti A; Cosenza LC; Zuccato C; Bianchi N; Breda L; Rivella S; Bresciani A; Bisbocci M; Borgatti M; Gambari R
Anal Bioanal Chem; 2019 Nov; 411(29):7669-7680. PubMed ID: 31273412
[TBL] [Abstract][Full Text] [Related]
33. Fetal hemoglobin in sickle cell anemia: relation to regulatory sequences cis to the beta-globin gene. Multicenter Study of Hydroxyurea.
Lu ZH; Steinberg MH
Blood; 1996 Feb; 87(4):1604-11. PubMed ID: 8608254
[TBL] [Abstract][Full Text] [Related]
34. Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.
Antoniou P; Hardouin G; Martinucci P; Frati G; Felix T; Chalumeau A; Fontana L; Martin J; Masson C; Brusson M; Maule G; Rosello M; Giovannangeli C; Abramowski V; de Villartay JP; Concordet JP; Del Bene F; El Nemer W; Amendola M; Cavazzana M; Cereseto A; Romano O; Miccio A
Nat Commun; 2022 Nov; 13(1):6618. PubMed ID: 36333351
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
Cui S; Engel JD
Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of globin gene modifiers encountered in fetuses during antenatal diagnosis of hemoglobinopathies.
Mehta P; Sawant P; Gorivale M; Nadkarni A; Colah R; Mukherjee MB
Int J Lab Hematol; 2020 Aug; 42(4):482-491. PubMed ID: 32412692
[TBL] [Abstract][Full Text] [Related]
38. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy.
Ikuta T; Kan YW; Swerdlow PS; Faller DV; Perrine SP
Blood; 1998 Oct; 92(8):2924-33. PubMed ID: 9763579
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.
Gambari R; Waziri AD; Goonasekera H; Peprah E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673849
[TBL] [Abstract][Full Text] [Related]
40. Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice.
Costa FC; Fedosyuk H; Chazelle AM; Neades RY; Peterson KR
PLoS Genet; 2012; 8(12):e1003155. PubMed ID: 23284307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
